Ipek Kivilcim Oguzulgen
Overview
Explore the profile of Ipek Kivilcim Oguzulgen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Celebi Sozener Z, Oguzulgen I, Ozalp Ates F, Baccioglu A, Argun Baris S, Ediger D, et al.
J Asthma
. 2025 Feb;
:1-11.
PMID: 39932533
Objective: The obese-asthma phenotype has gradually increased in the last few years. We aimed to assess the differences between obese and non-obese patients with asthma. Methods: This research is a...
2.
Arslan B, Turk M, Hayme S, Aydin O, Gokmen D, Koycu Buhari G, et al.
Clin Transl Allergy
. 2025 Jan;
15(1):e70018.
PMID: 39865387
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death. Objective:...
3.
Beyaz S, Erdinc M, Hayme S, Aslan A, Aydin O, Gokmen D, et al.
Allergol Immunopathol (Madr)
. 2025 Jan;
53(1):12-25.
PMID: 39786871
Montelukast, a leukotriene receptor antagonist (LTRA) approved for the treatment of asthma and allergic rhinitis, is widely used, though real-world data on its application in asthma management remain limited. This...
4.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen I, Soyyigit S, et al.
Respir Med
. 2024 Dec;
236:107883.
PMID: 39617354
Current guidelines recommend adding long-acting muscarinic antagonists (LAMAs) in patients with uncontrolled asthma, despite the use of moderate to high doses of inhaled steroid-long-acting beta agonists (ICS/LABA). This study aims...
5.
Kayalar O, Duru Cetinkaya P, Eldem V, Argun Baris S, Kokturk N, Kuralay S, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205185
The multisystemic effects of COVID-19 may continue for a longer time period following the acute phase, depending on the severity of the disease. However, long-term systemic transcriptomic changes associated with...
6.
Damadoglu E, Aktas O, Gemicioglu B, Yilmaz N, Bozkus F, Ayhan V, et al.
Turk J Med Sci
. 2024 May;
54(1):309-315.
PMID: 38812643
Background/aim: Characteristics of asthma in the elderly population is not well-known. The aim of the present study was to evaluate asthma in the elderly population, to compare disease characteristics between...
7.
Celik G, Aydin O, Sen E, Demir T, Gemicioglu B, Kiyan E, et al.
Tuberk Toraks
. 2024 Apr;
72(1):25-36.
PMID: 38676592
Introduction: Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) have a greater disease burden than those with COPD or asthma alone. In this study, it was aimed to determine...
8.
Celik G, Aydin O, Damadoglu E, Baccioglu A, Kepil Ozdemir S, Bavbek S, et al.
Thorac Res Pract
. 2023 Nov;
24(6):309-324.
PMID: 37909830
Introduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be...
9.
Yildiz Y, Ozturk Sahin B, Demir M, Demir S, Ciftci B, Kokturk N, et al.
Tuberk Toraks
. 2023 Sep;
71(3):261-272.
PMID: 37740629
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care...
10.